Viewing Study NCT01640535


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2025-12-31 @ 6:10 AM
Study NCT ID: NCT01640535
Status: COMPLETED
Last Update Posted: 2013-04-08
First Post: 2012-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-06
Start Date Type: None
Primary Completion Date: 2013-02
Primary Completion Date Type: ACTUAL
Completion Date: 2013-02
Completion Date Type: ACTUAL
First Submit Date: 2012-07-10
First Submit QC Date: None
Study First Post Date: 2012-07-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-04-04
Last Update Post Date: 2013-04-08
Last Update Post Date Type: ESTIMATED